CLOV icon

Clover Health Investments

3.74 USD
+0.02
0.54%
At close Jan 14, 4:00 PM EST
After hours
3.73
-0.01
0.27%
1 day
0.54%
5 days
4.18%
1 month
19.87%
3 months
-9.22%
6 months
136.71%
Year to date
19.49%
1 year
291.30%
5 years
-76.48%
10 years
-76.48%
 

About: Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.

Employees: 552

0
Funds holding %
of 6,815 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

155% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 22

153% more capital invested

Capital invested by funds: $91.5M [Q2] → $232M (+$140M) [Q3]

124% more call options, than puts

Call options by funds: $20.7M | Put options by funds: $9.28M

26% more funds holding

Funds holding: 124 [Q2] → 156 (+32) [Q3]

1.87% more ownership

Funds ownership: 18.29% [Q2] → 20.16% (+1.87%) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 33

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$6
60%
upside
Avg. target
$6
60%
upside
High target
$6
60%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Craig-Hallum
Matt Hewitt
54% 1-year accuracy
13 / 24 met price target
60%upside
$6
Buy
Initiated
17 Dec 2024

Financial journalist opinion

Based on 6 articles about CLOV published over the past 30 days

Neutral
GlobeNewsWire
1 day ago
Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
WILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growth of its Medicare Advantage (MA) membership during the most recent Annual Election Period (AEP). The Company enters 2025 with over 100,000 members, approximately 95% of whom are enrolled in Clover's flagship 4-Star PPO plan.
Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
Neutral
GlobeNewsWire
1 week ago
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counterpart Assistant technology within Duke Connected Care (DCC), a recognized leader in accountable care and part of the prestigious Duke University Health System. Counterpart is a subsidiary of Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover Health”).
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
Positive
Seeking Alpha
3 weeks ago
Insurtechs Shine On Wall Street In 2024 As Managed Care Struggles
Insurance technology companies were some of the best performing US insurers on Wall Street over the course of 2024, while the managed care sector had a less resilient year. Root Inc., Clover Health Investments Corp., Hippo Holdings Inc. and Lemonade Inc. were the top four performers for insurers with a market cap greater than $300 million for the year.
Insurtechs Shine On Wall Street In 2024 As Managed Care Struggles
Positive
Zacks Investment Research
3 weeks ago
4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run
Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.
4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run
Positive
Seeking Alpha
3 weeks ago
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with better adjusted EBITDA and reduced net loss, indicating progress towards profitability. Wall Street remains optimistic, with positive ratings and a potential 46% upside, bolstered by a Medicare Advantage PPO plan upgrade.
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
Neutral
GlobeNewsWire
4 weeks ago
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time.
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
Neutral
Seeking Alpha
1 month ago
Clover Health: Balancing Innovation And Challenges
Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 rating for its PPO plan, indicating improved quality of care and potential for higher CMS reimbursements. Despite a slight membership decline, Clover's financial efficiency has improved, with net income losses decreasing significantly from 2022 to 2024.
Clover Health: Balancing Innovation And Challenges
Neutral
Zacks Investment Research
1 month ago
Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher
Positive
Zacks Investment Research
1 month ago
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
Positive
Seeking Alpha
1 month ago
Clover Health: Buy The Dip, Reap The Rewards
Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgrade to 4 stars for payment year 2026 could help it increase its market share and secure more deals for Counterpart Assistant.
Clover Health: Buy The Dip, Reap The Rewards
Charts implemented using Lightweight Charts™